Variant report
Variant | esv3335948 |
---|---|
Chromosome Location | chr11:56262175-56271957 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:10)
- CpG islands (count:124)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:10 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | NFYB | chr11:56267551-56267744 | GM12878 | blood: | n/a | n/a |
2 | NR2F2 | chr11:56265096-56265541 | K562 | blood: | n/a | n/a |
3 | PAX5 | chr11:56264183-56264371 | GM12878 | blood: | n/a | n/a |
4 | POLR2A | chr11:56263718-56263747 | GM12878 | blood: | n/a | n/a |
5 | POLR2A | chr11:56266182-56266205 | MCF-7 | breast: | n/a | n/a |
6 | POLR2A | chr11:56266364-56266377 | ProgFib | skin: | n/a | n/a |
7 | POLR2A | chr11:56268274-56268297 | A549 | lung: | n/a | n/a |
8 | POLR2A | chr11:56266251-56266274 | MCF-7 | breast: | n/a | n/a |
9 | POLR2A | chr11:56266214-56266244 | MCF-7 | breast: | n/a | n/a |
10 | SPI1 | chr11:56270481-56270629 | K562 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:56264782-56264832 | NB4 | blood: | n/a |
2 | chr11:56264637-56264687 | GM12891 | blood: | n/a |
3 | chr11:56264782-56264832 | NB4 | blood: | n/a |
4 | chr11:56264637-56264687 | GM12891 | blood: | n/a |
5 | chr11:56264782-56264832 | HEK293 | kidney: | embryo |
6 | chr11:56264637-56264687 | K562 | blood: | n/a |
7 | chr11:56264637-56264687 | HCT-116 | colon: | n/a |
8 | chr11:56264782-56264832 | HIPEpiC | eye: | n/a |
9 | chr11:56264637-56264687 | NH-A | brain: | n/a |
10 | chr11:56264782-56264832 | PrEC | prostate: | n/a |
11 | chr11:56264782-56264832 | AG09319 | gingival: | n/a |
12 | chr11:56264782-56264832 | SAEC | small airway: | n/a |
13 | chr11:56264637-56264687 | ProgFib | skin: | n/a |
14 | chr11:56264637-56264687 | Hela-S3 | cervix: | n/a |
15 | chr11:56264637-56264687 | LNCaP | prostate: | n/a |
16 | chr11:56264637-56264687 | IMR90 | lung: | fetal |
17 | chr11:56264782-56264832 | AG09309 | skin: | n/a |
18 | chr11:56264782-56264832 | Jurkat | blood: | n/a |
19 | chr11:56264782-56264832 | HAEpiC | amniotic membrane: | n/a |
20 | chr11:56264637-56264687 | HPAEpiC | pulmonary alveolar: | n/a |
21 | chr11:56264637-56264687 | CMK | blood: | n/a |
22 | chr11:56264637-56264687 | GM12878 | blood: | n/a |
23 | chr11:56264637-56264687 | HIPEpiC | eye: | n/a |
24 | chr11:56264637-56264687 | RPTEC | kidney: | n/a |
25 | chr11:56264637-56264687 | NT2-D1 | testis: | n/a |
26 | chr11:56264637-56264687 | BJ | skin: | n/a |
27 | chr11:56264637-56264687 | HepG2 | liver: | n/a |
28 | chr11:56264782-56264832 | AG04449 | skin: | fetal |
29 | chr11:56264782-56264832 | HepG2 | liver: | n/a |
30 | chr11:56264782-56264832 | HL-60 | blood: | n/a |
31 | chr11:56264637-56264687 | ovcar-3 | ovarian: | n/a |
32 | chr11:56264782-56264832 | ovcar-3 | ovarian: | n/a |
33 | chr11:56264782-56264832 | NH-A | brain: | n/a |
34 | chr11:56264782-56264832 | MCF-7 | breast: | n/a |
35 | chr11:56264637-56264687 | SKMC | muscle: | n/a |
36 | chr11:56264782-56264832 | Hela-S3 | cervix: | n/a |
37 | chr11:56264782-56264832 | GM06990 | blood: | n/a |
38 | chr11:56264637-56264687 | AG04450 | lung: | fetal |
39 | chr11:56264637-56264687 | PFSK-1 | brain: | n/a |
40 | chr11:56264782-56264832 | IMR90 | lung: | fetal |
41 | chr11:56264637-56264687 | ECC-1 | luminal epithelium: | n/a |
42 | chr11:56264637-56264687 | SK-N-SH | brain: | n/a |
43 | chr11:56264637-56264687 | HL-60 | blood: | n/a |
44 | chr11:56264782-56264832 | HCT-116 | colon: | n/a |
45 | chr11:56264637-56264687 | A549 | lung: | n/a |
46 | chr11:56264782-56264832 | GM12891 | blood: | n/a |
47 | chr11:56264782-56264832 | MCF10A-Er-Src | breast: | n/a |
48 | chr11:56264782-56264832 | SK-N-SH_RA | brain: | n/a |
49 | chr11:56264637-56264687 | T-47D | breast: | n/a |
50 | chr11:56264782-56264832 | NT2-D1 | testis: | n/a |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR5M7P | TF binding region |
OR5M8 | TF binding region |
ENSG00000254411 | TF binding region |
OR5M7P | CpG island |
OR5M8 | CpG island |
ENSG00000254411 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs191181216 | chr11:56262182-56262183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs374495025 | chr11:56262197-56262198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs558564388 | chr11:56262216-56262217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs577494398 | chr11:56262236-56262237 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs545334678 | chr11:56262246-56262247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs560079648 | chr11:56262286-56262287 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs572166046 | chr11:56262310-56262311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs564977708 | chr11:56262373-56262374 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs542478528 | chr11:56262411-56262412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs183350098 | chr11:56262416-56262417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs56163075 | chr11:56262468-56262469 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs549779936 | chr11:56262495-56262496 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs77077446 | chr11:56262511-56262512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs532843741 | chr11:56262521-56262522 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs10896466 | chr11:56262562-56262563 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs75570680 | chr11:56262594-56262595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs150110720 | chr11:56262607-56262608 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs137919345 | chr11:56262707-56262708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs548516885 | chr11:56262723-56262724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs567290731 | chr11:56262741-56262742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs75864533 | chr11:56262745-56262746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs569801578 | chr11:56262787-56262788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs537179795 | chr11:56262866-56262867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs558525746 | chr11:56262942-56262943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs570553520 | chr11:56262955-56262956 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs370160442 | chr11:56262994-56262995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs113974944 | chr11:56262997-56262998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs138846037 | chr11:56263002-56263003 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs111957463 | chr11:56263011-56263012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs572266561 | chr11:56263023-56263024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs112630402 | chr11:56263028-56263029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs542791400 | chr11:56263031-56263032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs531956158 | chr11:56263057-56263058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs554831312 | chr11:56263081-56263082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs141307940 | chr11:56263098-56263099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs638436 | chr11:56263112-56263113 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs61902909 | chr11:56263116-56263117 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs638452 | chr11:56263118-56263119 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs147011608 | chr11:56263137-56263138 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs559965309 | chr11:56263139-56263140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs655887 | chr11:56263235-56263236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs655886 | chr11:56263237-56263238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs530364672 | chr11:56263261-56263262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs655821 | chr11:56263275-56263276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs548743929 | chr11:56263307-56263308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs569962808 | chr11:56263335-56263336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs530903596 | chr11:56263362-56263363 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs552212674 | chr11:56263386-56263387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs570615411 | chr11:56263392-56263393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs534982627 | chr11:56263410-56263411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Pituitary adenoma | 18645599 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:56261800-56263200 | Weak transcription | Fetal Brain Male | brain |
2 | chr11:56263200-56263600 | Enhancers | Fetal Brain Male | brain |
3 | chr11:56269400-56271000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
4 | chr11:56271200-56271800 | Enhancers | Fetal Brain Male | brain |
5 | chr11:56271800-56273000 | Weak transcription | Fetal Brain Male | brain |